A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver ...

The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in ...

Liver cancer is when a malignant tumor starts in or on the liver. Excess alcohol, hepatitis, and diabetes are risk factors. Learn more here about the symptoms, treatment, and how to prevent liver ...

A research team led by Prof. Hai Li from the Hefei Institutes of Physical Science, Chinese Academy of Sciences, has become the first to systematically explore how large language models (LLMs) can ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...

The FDA approved Y-90 resin microspheres for the treatment of unresectable hepatocellular carcinoma, according to a press ...

A noninvasive ultrasound treatment that destroys liver tumours without surgery or radiation will soon be offered on the NHS in Cambridge in a European first.

Researchers from Virginia Commonwealth University's (VCU) Massey Comprehensive Cancer Center have discovered a new genetic target that could possibly shape the future of treatment for liver cancer.

The FDA approves SIR-Spheres Y-90 microspheres for treating unresectable hepatocellular carcinoma, showcasing impressive ...

Legendary wide receiver Randy Moss, whose electrifying 14-season NFL career included standout runs with the Minnesota Vikings ...

Electra D. Paskett, PhD, MSPH, FACE, FAACR, was elected as a fellow to the American Association for Cancer Research Academy ...

Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the U.S. approved to treat both ...